EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Oligometastatic pancreatic cancer: current state of management and emerging therapies

Andrii Khomiak iD, Nicole B Balmaceda, Sumaya A Ghaffar, Christopher H Lieu, Marco Del Chiaro, Wells A Messersmith, Robert W Lentz iD

The Oncologist · 04.06.2025 · 30 (6)

DOI: 10.1093/oncolo/oyaf154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Oncologist, online erschienen am 19.06.2025. Verfasst von Andrii Khomiak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligometastatic pancreatic cancer is a distinct clinical entity with limited metastatic burden. This unique subset of patients harbor a favorable tumor biology and potentially better prognosis compared to widespread metastatic disease. This review explores definitions of oligometastatic pancreatic cancer and the current state of management, including systemic therapy, surgery, and locoregional techniques. While there are few randomized clinical trials directing the management of oligometastatic pancreatic cancer, we provide insights into the treatment challenges, evolving therapeutic approaches, and future directions for this unique subset of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansNeoplasm Metastasis

Stichwörter der Autor:innen

locoregional therapymetastasis-directed therapyoligometastatic diseasepancreatic ductal adenocarcinomasurgical metastasectomysystemic therapy

Autor:innen und Institutionen

  • Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.

ORCID-Profile: Andrii Khomiak, Robert W Lentz

Zitieren

APA

Khomiak, A., Balmaceda, N. B., Ghaffar, S. A., Lieu, C. H., Del Chiaro, M., Messersmith, W. A., & Lentz, R. W. (2025). Oligometastatic pancreatic cancer: current state of management and emerging therapies. The Oncologist, 30(6). https://doi.org/10.1093/oncolo/oyaf154

Vancouver

Khomiak A, Balmaceda NB, Ghaffar SA, Lieu CH, Del Chiaro M, Messersmith WA, et al. Oligometastatic pancreatic cancer: current state of management and emerging therapies. The Oncologist. 2025;30(6). doi:10.1093/oncolo/oyaf154

BibTeX
@article{Khomiak2025,
  author = {Khomiak, Andrii and Balmaceda, Nicole B and Ghaffar, Sumaya A and Lieu, Christopher H and Del Chiaro, Marco and Messersmith, Wells A and Lentz, Robert W},
  title = {Oligometastatic pancreatic cancer: current state of management and emerging therapies},
  journal = {The Oncologist},
  year = {2025},
  volume = {30},
  number = {6},
  doi = {10.1093/oncolo/oyaf154}
}
Kostenlos starten →